Enterprise Innovation Institute

Asahi Kasei Bioprocess and Axolabs announce strategic partnership to accelerate oligonucleotide therapeutics development

Posted on: April 30, 2024

Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.

Read full post: Read More